In January 2015, The Jack Brewer Foundation (JBF Worldwide)(insert link) and Immune Therapeutics, Inc. announced first-of-its-kind donation program to improve access to treatment to prevent cervical cancer that until now has been unavailable to the women of Malawi, Africa.
The program is designed to deliver a preventive and simple procedure that can be performed in a clinic setting without the use of a laboratory and further allows for immediate treatment of any precancerous lesions utilizing the Wallach LL100 Cryosurgical systems. The program initially entails the donation of multiple units of these systems to Queen Elizabeth Central Hospital and several clinics throughout Malawi.
For more information regarding this project contact Investor Relations Counsel:
Investor Relations Partners